Intra-amniotic or intravenous injection of dehydroepiandrosterone sulphate: simultaneous changes in steroid levels in amniotic fluid and maternal serum

Clin Endocrinol (Oxf). 1980 Mar;12(3):261-7. doi: 10.1111/j.1365-2265.1980.tb02709.x.

Abstract

Levels of unconjugated oestradiol-17 beta (E2) and testosterone (T) and total oestriol (E3) were measured hourly to 6 h after intra-amniotic (i.a.) (100--200 mg) or intravenous (i.v.) (100 mg) injection of dehydroepiandrosterone sulphate (DHEA-S) in a series of twenty-six women with mid-trimester abortion. Amniotic fluid E2 and T levels were elevated significantly 1--6 h after the i.a. injection of DHEA-S, while the E3 level in amniotic fluid did not change. The i.a. administration also induced significant rises in serum E2 and T levels between 1 and 6 h and in the serum E3 level between 2--6 h. The i.v. injection of DHEA-S was accompanied by significantly elevated serum levels of E2 and T, while the E3 concentration remained unchanged. It appears that following maternal i.v. administration or an amniotic fluid injection, DHEA-S is rapidly converted to E2 and T, and these accumulate in both the maternal circulation and the amniotic fluid. E3, however, is formed only after i.a. administration of DHEA-S, and is selectively transported to the maternal blood.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Amnion
  • Amniotic Fluid / metabolism*
  • Dehydroepiandrosterone / administration & dosage
  • Dehydroepiandrosterone / pharmacology*
  • Estradiol / blood
  • Estradiol / metabolism*
  • Estriol / blood
  • Estriol / metabolism*
  • Female
  • Humans
  • Injections
  • Injections, Intravenous
  • Maternal-Fetal Exchange*
  • Pregnancy
  • Pregnancy Trimester, Second
  • Testosterone / blood
  • Testosterone / metabolism*

Substances

  • Testosterone
  • Dehydroepiandrosterone
  • Estradiol
  • Estriol